Breast Cancer Research – Can weight loss drugs prevent breast cancer recurrence?
That’s the question researchers aim to answer in a new, first-of-its-kind, clinical trial in North Texas By Bianca Castro • Published April 30, 2025 • Updated on April 30, 2025 at 10:52 pm Researchers in Dallas are investigating the potential of weight loss medications, specifically a drug called tirzepatide, as a novel approach to reducing the risk of breast cancer recurrence in women who are […]
Austin VC firm invests in latest weight loss trend — GLP-1 consumer packaged goods
Full Frame Growth Partners is a minority investor in California-based Supergut, a company making powdered supplements and bars to boost the GLP-1 hormone. Here’s why its founder and managing partner is investing in the company. Plus, read more about the shift GLP-1 drugs are making in the CPG world.
GLP-1 receptor agonists for the treatment of alcohol use disorder
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, are widely used in the treatment of metabolic disorders, including type 2 diabetes (T2D) and obesity. These medications primarily function by enhancing insulin secretion; however, emerging evidence suggests that the effects extend beyond metabolic regulation. In this issue of the JCI, Farokhnia et al. evaluated the effects […]
The GLP-1 Saga Continues, And How
Keeping up with the GLP-1 area is a full time job by itself. First off, you have the recent development that these drugs are no longer considered to officially be in shortage, which (in theory) closes the regulatory loophole that compounding pharmacies have been using to offer their own versions. And that is already showing […]
10 recent healthcare industry lawsuits, settlements
From the Supreme Court ruling against hospitals in a DSH pay formula case to five Florida hospitals suing Leapfrog over safety rankings, here are 10 recent healthcare industry lawsuits, settlements and legal developments that Becker’s has reported since April 22: 1. Gilead Sciences agreed to pay $202 million to resolve allegations that it violated the […]
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
Related Stocks: NAS:ILMN,
Real World Successes: How Data Analytics are Transforming Employee Benefits Programs
In today’s complex benefits landscape, employers face mounting challenges in managing healthcare costs, designing effective plans, and engaging employees. With healthcare costs projected to rise 8% in 2025—the highest increase in over a decade—many organizations are turning to data analytics to transform their approach to benefits management. Today’s Employee Benefits Challenges Employers and benefit advisors […]
Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies – PR Newswire
Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies PR NewswireView Full Coverage on Google News
Diabetes and weight loss drugs could help treat a type of liver disease. Here’s what to know.
A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for diabetes and obesity could also help people with a type of liver disease. CBS News contributor Dr. Celine Gounder explains the findings.
STAT+: Eli Lilly shares fall as competitor Novo notches coverage win for obesity drug
Shares of Eli Lilly dropped in pre-market trading Thursday, as competitor Novo Nordisk secured a major win on insurance coverage of its obesity drug and as Lilly reported first-quarter earnings that fell short of what investors wanted to see. CVS Caremark, the largest pharmacy benefit manager in the U.S., announced Thursday that starting in July, […]